Articles related to Immunotherapy
TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer
A group of investigators at Moffitt Cancer Center initiated a trial to determine if non-small cell lung cancer patients could have response to TIL therapy Read More
Combining Immunotherapy in Triple Negative Breast Cancer Treatment
Responses have been seen in some patients with triple-negative breast cancer (TNBC), signaling a potential role for immunotherapy in this tumor type. Read More
Immunotherapy Clinical Trial Brought Renewed Hope To Lung Cancer Patient
My husband and I celebrated our 50th wedding anniversary last year and know without a doubt that I would not be alive today if we had not sought treatment at Moffitt Cancer Center. Read More
Moffitt’s Top Research Developments of 2017: Novel Combination Approach to Lung Cancer Wins Moffitt a Stand Up To Cancer Grant
The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More
Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt
The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More
Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy
Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More
Infographic: How CAR T Therapy Works to Fight Cancer
CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More
What is CAR T Therapy?
Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More
CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma
Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More
Research Spotlight: Dr. Abate-Daga Discusses the Progress of Immunotherapy
Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More
Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'
Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More